Ticker

No recent analyst price targets found for ONTTF.

Latest News for ONTTF

Oxford Nanopore rises on strong 2025 revenue growth

Shares in Oxford Nanopore Technologies PLC (LSE:ONT) rose 8% to 152p on Monday after the DNA sequencing group said its revenue for 2025 would come in slightly ahead of guidance, helped by double-digit growth across all regions and customer markets. The company expects to report revenue of between £223 million and £224 million for the year to 31 December, up around 22% on a reported basis and 24% at constant currency.

Proactive Investors • Jan 12, 2026
Oxford Nanopore Receives Regulatory Approval for its First Diagnostic Device in the UK and Europe

OXFORD, England--(BUSINESS WIRE)-- #Nanopore--Oxford Nanopore Technologies today announces that the GridION™ Dx is now both CE and UKCA marked, making it the company's first IVD device registered in the UK and Europe. The CE and UKCA certification confirms that GridION™ Dx meets stringent international standards for quality, safety, and performance, positioning Oxford Nanopore for future adoption in regulated…

Business Wire • Jan 12, 2026

🧮 Earnings Move Analyzer

Insider Trading

No insider trades found for ONTTF.

No Senate trades found for ONTTF.

No House trades found for ONTTF.

Options Chain

Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.

Scroll to Top